Sb Pharmco Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SB PHARMCO
SB PHARMCO has two approved drugs.
Drugs and US Patents for Sb Pharmco
Expired US Patents for Sb Pharmco
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Sb Pharmco | AVANDAMET | metformin hydrochloride; rosiglitazone maleate | TABLET;ORAL | 021410-003 | Oct 10, 2002 | 8,236,345 | ⤷ Start Trial |
| Sb Pharmco | AVANDAMET | metformin hydrochloride; rosiglitazone maleate | TABLET;ORAL | 021410-004 | Aug 25, 2003 | 8,236,345 | ⤷ Start Trial |
| Sb Pharmco | AVANDAMET | metformin hydrochloride; rosiglitazone maleate | TABLET;ORAL | 021410-002 | Oct 10, 2002 | 8,236,345 | ⤷ Start Trial |
| Sb Pharmco | AVANDAMET | metformin hydrochloride; rosiglitazone maleate | TABLET;ORAL | 021410-001 | Oct 10, 2002 | 8,236,345 | ⤷ Start Trial |
| Sb Pharmco | AVANDAMET | metformin hydrochloride; rosiglitazone maleate | TABLET;ORAL | 021410-005 | Aug 25, 2003 | 8,236,345 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for SB PHARMCO drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Tablets | 1 mg/4 mg, 2 mg/4 mg and 4 mg/4 mg | ➤ Subscribe | 2006-12-22 |
| ➤ Subscribe | Tablets | 1 mg/ 500 mg, 2 mg/ 500mg, 4 mg/ 500 mg, 2 mg/ 1000 mg and 4 mg/ 1000 mg | ➤ Subscribe | 2004-10-22 |
| ➤ Subscribe | Tablets | 8 mg/2 mg and 8 mg/4 mg | ➤ Subscribe | 2008-05-30 |
Similar Applicant Names
Here is a list of applicants with similar names.

